Science & Enterprise subscription

Follow us on Twitter

  • Researchers from academic engineering and biology labs designed an electronic process for sterilizing N95 respirato… https://t.co/F669oYynGB
    about 2 hours ago
  • New post on Science and Enterprise: Labs Creating Mask Electronic Sterilization Process https://t.co/uzaixORtKU #Science #Business
    about 2 hours ago
  • Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a t… https://t.co/N4aQ3XtLUA
    about 8 hours ago
  • New post on Science and Enterprise: Merck Inks Three Covid-19 Vaccine, Therapy Deals https://t.co/cX7doWjArf #Science #Business
    about 8 hours ago
  • Vietnam War Memorial #flickr https://t.co/VwB3z4ZQrF ... photo from #MemorialDay 2010 ... @jaketapper
    about 1 day ago

Please share Science & Enterprise

Psychiatric Drug Maker Raises $80M in Venture Funds

Psilocybe aztecorum

A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing. . . . → Read More: Psychiatric Drug Maker Raises $80M in Venture Funds

Infographic – Biotech Remains Hottest Venture Sector

A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars. . . . → Read More: Infographic – Biotech Remains Hottest Venture Sector

Venture Deals Decline in Q1, Biotech Sizzles Again

The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors. . . . → Read More: Venture Deals Decline in Q1, Biotech Sizzles Again

Infographic – Biotech Index Dives, Rebounds

NBI Jan-Apr 2020

We check in from time to time on the Nasdaq Biotechnology Index as an indicator of the overall health of research-based businesses in the U.S. . . . → Read More: Infographic – Biotech Index Dives, Rebounds

Venture-Backed Start-Ups to Get Small Biz Loans

Investing monitor

An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for more start-ups funded by venture capital. . . . → Read More: Venture-Backed Start-Ups to Get Small Biz Loans

Life Science Venture Funds Raise $2.56B for Start-Ups

Investment graphic

Two investment companies specializing in health care and life sciences revealed new venture funds to finance young enterprises with innovative technologies. . . . → Read More: Life Science Venture Funds Raise $2.56B for Start-Ups

Start-Up Licenses Immunotherapies in $880M Deal

Human T-cell

A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal

Venture Fund to Back Covid-19 Start-Ups

Caspr Biotech

A life science incubator company plans to fund eight start-up enterprises developing diagnostics, vaccines, or treatments for the Covid-19 pandemic. . . . → Read More: Venture Fund to Back Covid-19 Start-Ups

Engineered Probiotic Maker Gains $2.3M Seed Funding

Zack Abbott and John Oliver

A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line. . . . → Read More: Engineered Probiotic Maker Gains $2.3M Seed Funding

Wearable Defibrillator Maker Gains $145.6M

Heartbeat graphic

The developer of a patch device that monitors and adjusts heart rhythms to prevent sudden cardiac death is raising $145.6 million in a new venture funds. . . . → Read More: Wearable Defibrillator Maker Gains $145.6M